Application of sertaconazole for the treatment of smooth skin microsporia

Khamaganova I.V.; Karamova A.É.; Shekrota A.G.; Makushina Z.V.

doi:https://doi.org/

Khamaganova I.V.

Russian State Medical University, Moscow

Karamova A.É.

Russian State Medical University, Moscow

Shekrota A.G.

Children's Infectious Hospital, Moscow

Makushina Z.V.

Children's Infectious Hospital, Moscow

Application of sertaconazole for the treatment of smooth skin microsporia

Authors:

Khamaganova I.V., Karamova A.É., Shekrota A.G., Makushina Z.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(3): 32‑36

Read: 1911 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Khamaganova IV, Karamova AÉ, Shekrota AG, Makushina ZV. Application of sertaconazole for the treatment of smooth skin microsporia. Russian Journal of Clinical Dermatology and Venereology. 2010;8(3):32‑36. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Place of sertaconazole, amorolfine and ketoconazole in the treatment of mycoses of the skin and its appendages: description of cases and literature review. Russian Journal of Clinical Dermatology and Venereology. 2025;(3):343-348

From atopy to infection — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):430-436

Clinical and psychopathological features of treatment-resistant schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

Genome instability of the cholera agent: role in the evolution of pathogenicity, drug resistance and adaptation to a changing environment. Molecular Genetics, Microbiology and Virology. 2025;(2):3-13

Abstract:

Keywords:

smooth skin microsporia

sertaconazole

resistance

mycotic infection

Authors:

Khamaganova I.V.

Russian State Medical University, Moscow

Karamova A.É.

Russian State Medical University, Moscow

Shekrota A.G.

Children's Infectious Hospital, Moscow

Makushina Z.V.

Children's Infectious Hospital, Moscow

Close metadata

References:

Karamova A.E., Khamaganova I.V., Kuleshova S.V. Dermatofitii retsidiviruyushchego techeniya: opyt primeneniya sertakonazola. Klin dermatol venerol 2006; 3: 33-34.
Kubanova A.A., Potekaev N.S., Potekaev N.N. Rukovodstvo po prakticheskoi mikologii. M 2001; 198.
Sergeev A.Yu., Sergeev Yu.V. Gribkovye infektsii. Rukovodstvo dlya vrachei. M: BINOM-Press 2003; 289.
Sergeev Yu.V., Shpigel' B.I., Sergeev A.Yu. Farmakoterapiya mikozov. M: Meditsina dlya vsekh 2003; 200.
Skripkin Yu.K., Selisskii G.D., Fedorov S.M., Khubieva F.V. Bolezni kozhi i infektsii, peredavaemye polovym putem M: Meditsinskoe informatsionnoe agentstvo 2003; 544.
Sokolova T.V., Mokronosova M.A., Klivitskaya N.A., Glushakova A.M. Eksperimental'noe obosnovanie spetsificheskoi aktivnosti sertakonazola na Malassezia spp. pri atopicheskom dermatite. Immunopatol allergol, infektol 2009; 2: 98-99.
Croxtall J.D., Plosker G.L. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynecology. Drugs 2009; 69: 3: 339-359.
Elewski B.E. Safe and effective treatment of seborrheic dermatitis. Cutis 2009; 83: 6: 333-338.
Gil-Lamaignere C., Muller F.M. Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr. Int J Antimicrob Agents 2004; 23: 5: 520-523.
Leber R., Fuchsbischler S., Klobučnikova V. et al. Molecular Mechanism of Terbinafine Resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother 2003; 47: 12: 3890-3900.
Liu W. Extra Copies of Aspergillus fumigatus Squalene Epoxidase Gen Resistance to Antifungals in A. fumigatus. Antimicrob Agents Chemother 2004; 48: 7: 2490-2496.
Pfaller M.A., Messer S.A., Boyken L. et al. Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12 796 clinical isolates of Candida spp. J Clin Microbiol 2004; 42: 7: 3137-3141.
Ribotsky B.M. Sertaconazole nitrate cream 2% for the treatment of tinea pedis. Cutis 2009; 83: 5: 274-277.
Sojakova M., Liptajova D., Borovsky M., Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 2004; 157: 2: 163-169.
Sur R., Babad J.M., Garay M. et al. Anti-inflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2 - PGE 2 pathway. J Invest Dermatol 2008; 128: 2: 336-344.